YOLFTbeta
SpectraCure AB

SpectraCure AB

SPEC · ST · Healthcare / Medical Devices

0.0137SEK-0.00 (-13.84%)

Price History

Full chart

Market Stats

Previous Close0.0159
Open0.016
Day Range0.0134 – 0.0163
52-Week Range0.0172 – 0.2415
Volume18.36M
Market Cap13.02M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.09
Dividend Yield0.00%
Beta0.46
50-Day Avg0.0278
200-Day Avg0.0727

About

SpectraCure AB (publ) engages in the development of cancer treatment system in Sweden. It develops Q-PRO, a laser unit; IDOSE software platform, which calculates the optimal laser light dose and placement of the optical fibers; and disposable items comprising needles, optical fibers, and light-sensitive medication. The company was incorporated in 2003 and is based in Lund, Sweden.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEODr. Johannes Swartling Ph.D.
  • Employees13
  • HeadquartersGasverksgatan 1, Lund, Sweden, 222 29, Sweden
  • Websitehttps://www.spectracure.com

Leadership

  • Dr. Johannes Swartling Ph.D.Chief Executive Officer · b. 1972
  • Ms. Fata MrsicChief Financial Officer
  • Mr. Marcelo Soto ThompsonChief Technology Officer
  • Ms. Mirjam JohanssonAdministrative Manager
  • Ms. Kristina HolstHead of Clinical Affairs · b. 1967

Financials

Income Statement

Currency: SEK2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue1.49M476.19K778.50K172.91K258.95K596.00K7631.21K5.75M539.00K318.00K19.53M868.00K
Growth (%)--68.04%+63.48%-77.79%+49.76%+130.16%-99.87%+58.72%+474631.63%-90.62%-41.00%+6042.14%-95.56%
Cost of Revenue67.73K-641.87K-249.43K-1.14M-1.55M-2.13M-2.62M-2.35M-1.39M-3.05M9.54M9.77M30.14M
Gross Profit1.42M1.12M1.03M1.31M1.81M2.72M2.62M2.35M1.39M3.58M-9.22M9.77M-30.14M
Gross Margin95.45%234.79%132.04%758.00%699.85%456.54%343088.20%194154.50%24.09%665.12%-2900.31%50.00%-3471.77%
Operating Expense7.02M5.17M6.78M8.13M10.51M12.34M16.91M18.82M25.80M30.56M12.13M34.25M24.22M
Operating Income-5.60M-4.06M-5.75M-6.82M-8.70M-9.62M-14.29M-16.46M-24.42M-26.98M-21.35M-24.48M-54.35M
Operating Margin-375.80%-851.79%-738.73%-3941.99%-3358.37%-1613.59%-1872608.13%-1359620.15%-424.72%-5005.19%-6714.15%-125.36%-6261.87%
EBITDA-3.09M-2.87M-5.69M-6.24M-7.53M-9.46M-11.35M-12.88M-20.43M-22.27M-20.97M-20.42M-24.22M
EBITDA Margin-207.69%-603.05%-730.68%-3606.06%-2907.23%-1587.25%-1487942.33%-1063748.97%-355.44%-4130.80%-6594.03%-104.55%-2790.09%
Net Income-5.73M-4.35M-5.88M-6.37M-8.70M-9.61M-13.69M-15.41M-23.34M-25.33M-20.44M-23.00M-56.08M
Net Income Margin-384.67%-912.64%-755.89%-3685.20%-3358.38%-1612.42%-1793577.98%-1272254.34%-406.00%-4698.70%-6427.99%-117.78%-6460.71%
Interest Expense-291.41K134.09K43.51K640224.00K276.00K245.00K182.00K522.00K468.00K1.25M
Interest Expense % of Total Revenue-61.20%17.22%25.16%0.02%0.00%29357.80%22791.08%4.26%33.77%164.15%2.40%144.47%

Balance Sheet

Currency: SEK2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets6.57M5.55M14.09M28.77M14.71M68.95M100.19M210.53M190.52M162.42M144.83M121.00M104.47M
Total Liabilities2.35M8.66M1.04M6.66M1.30M4.03M12.41M13.32M14.84M12.12M14.97M14.15M10.92M
Total Equity1.22M-3.11M13.06M22.11M13.41M64.92M87.78M197.22M175.68M150.30M129.86M106.86M93.55M
Cash448.58K182.65K8.15M381.67K2.44M45.08M54.21M157.24M129.69M93.18M56.95M18.27M13.53M
Total Debt------6.71M5.36M4.90M2.70M6.72M5.14M3.01M
Net Debt-448.58K-182.65K-8.15M-381.67K-2.44M-45.08M-47.49M-151.88M-124.79M-90.48M-50.23M-13.13M-10.52M

Cash Flow

Currency: SEK2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow--604.49K-9.71M-19.60M6.33M-8.97M-10.05M-9.40M-18.60M-22.96M-18.68M-21.83M-24.03M
Investing Cash Flow--675.53K-367.31K-3.62M-4.27M-9.39M-15.13M-10.58M-8.49M-11.35M-15.56M-15.28M-19.64M
Financing Cash Flow-1.01M18.05M15.42M67.48M50.61M34.32M123.02M-453.00K-2.20M-1.99M-1.57M38.92M
Capital Expenditure0675.53K367.31K3.80M4.27M9.39M15.13M10.58M8.49M10.12M15.77M15.28M19.64M
Free Cash Flow--1.28M-10.08M-23.40M2.06M-18.36M-25.18M-19.99M-27.09M-33.08M-34.45M-37.10M-43.67M
FCF to OCF-211.75%103.78%119.41%32.54%204.69%250.47%212.54%145.65%144.06%184.41%170.00%181.75%

Earnings

Report DateSep 30, 2015Dec 31, 2015Mar 31, 2016Jun 30, 2016Sep 30, 2016Dec 31, 2016May 23, 2017Aug 22, 2017Nov 11, 2017Feb 15, 2018Mar 31, 2018Jun 30, 2018Dec 27, 2018Feb 15, 2019May 23, 2019Aug 21, 2019Nov 12, 2019Feb 25, 2020Mar 31, 2020Jun 30, 2020Nov 12, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023May 15, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate--------------------------------------------
EPS Actual-0.02-0.02-0.01-0.02-0.01-0.01-0.03-0.04-0.04-0.04-0.01-0.02-0.03-0.04-0.03-0.05-0.04-0.04-0.01-0.02-0.02-0.02-0.02-0.02-0.02-0.02-0.02-0.02-0.02-0.02-0.02-0.02-0.02-0.01-0.06-0.02-0.02-0.02-0.02-0.06-0.07-0.01-0.01-0.01
Surprise--------------------------------------------
Timing------Pre-marketPre-marketPre-marketPre-market--After-hoursPre-marketPre-marketPre-marketAfter-hoursPre-market----------------Pre-market---------

Key Statistics & Ratios

Market Cap13.02M
Enterprise Value14.67M
Trailing P/E0.00
Forward P/E0.00
Price / Sales24.82
Price / Book0.14
EPS-0.09
Book Value0.164
Revenue (TTM)-242.00K
Gross Profit (TTM)12.34M
EBITDA-54.08M
Profit Margin0.00%
Operating Margin-2680.00%
Return on Equity-48.61%
Return on Assets-23.72%
Shares Outstanding735.49M
Shares Float532.17M
Beta0.46
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20221×
0.01Sep 1, 2022